| | |
EMG Business Management System Manual | Doc # epsg1026386 | |
Rev. 112 |
| Page 12 of 35 |
|
|
|
4.2Strategic Planning (4.1.c, 4.2.1a, 5.4.1, and 7.1)
The strategic plan is developed at the EMG level encompassing all business processes and stating the direction, leadership, and transformation required to meet specific goals. EMG will improve customer satisfaction and earn unrivaled loyalty through personalized customer relationships. Capitalize on our product leadership. Create customer value and intimacy through innovative systems,
EMG has yearly strategy reviews at the Group level to ensure plans are consistent with changing market conditions. EMG focuses on customers, competitors and our offerings. After the strategy review, our annual financial plan is developed (SCALE: short term commitment and long term estimate) using the SPR (strategic plan review) as the baseline for profitability and ROIC (return on invested capital). Tactical reviews are held quarterly to review financial results, NPI revenues, market share, customer satisfaction, and employee satisfaction.
4.2.1Acquisitions:
a)Corporate Development (CD): Supports the ongoing assessment of Agilent‟s enterprise business portfolio to identify candidates for active abandonment or investment. CD insures strong links between the enterprise and Group strategies, focusing Agilent‟s overall prospects for top line growth and value creation. This site is designed to support the needs of those involved in transactions, integration, strategic planning, and new ventures within the businesses and corporate functions. http://corpdev.agilent.com/
b)EMG has developed an Acquisition Lifecycle (ALC) process that provides the EMG business with additional acquisition support not specifically covered by corporate development personnel and processes. ALC Web site, ALC Standard
4.2.2Discontinuance/Obsolescence strategy is determined in each business. The EMG Discontinuance Plan is the key document that is used to plan and execute the discontinuance and final obsolescence of products at the end of their lifecycle. The Discontinuance Plan is split into several sections, and a
The Corporate Discontinuance Process can be found at: http://wcosedoc.cos.agilent.com/stellent/groups/plc/documents/end_users/019602.doc
4.2.3Technology Development: (7.1)
a)The Technology Leadership Organization (TLO) as the central technology organization, leads the creation of EMG Strategy, makes R&D portfolio decisions, delivers breakthrough technology with clear competitive advantage, executes EMG R&D programs, guides EMG level architecture, and manages and improves EMG R&D Processes. http://emg.communications.agilent.com/tlo/
b)EMG also links to Agilent Labs to identify and transfer breakthrough technologies into our businesses. http://web.labs.agilent.com/
4.2.4General Outsourcing Requirements
The user of any printed copy of this controlled document is responsible for verifying it is the correct version prior to use. Hard copies are uncontrolled.
This manual contains links to subordinate documents that are restricted to Agilent personnel only
and may not work if accessing this document from a public site.
The current version is available at the EMG Document Map website: http://emg.communications.agilent.com/quality/bms/040318_docMap.asp
(c) Agilent Technologies, Inc. 2002, AGILENT TECHNOLOGIES
